These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 31797565)

  • 1. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
    Barden AE; Mas E; Croft KD; Phillips M; Mori TA
    Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
    Calder PC
    Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
    López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
    Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis.
    Maskrey BH; Megson IL; Rossi AG; Whitfield PD
    Mol Nutr Food Res; 2013 Aug; 57(8):1390-400. PubMed ID: 23417926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
    Serhan CN
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():44-8. PubMed ID: 19630766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
    González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
    FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and inflammatory processes: from molecules to man.
    Calder PC
    Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biosynthetic pathways of the protectins.
    Stenvik Haatveit Å; Hansen TV
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases.
    Miyata J; Arita M
    Allergol Int; 2015 Jan; 64(1):27-34. PubMed ID: 25572556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A; Amabile MI; Monti M; Muscaritoli M
    Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
    Serhan CN
    Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protectins: Their biosynthesis, metabolism and structure-functions.
    Vidar Hansen T; Serhan CN
    Biochem Pharmacol; 2022 Dec; 206():115330. PubMed ID: 36341938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
    Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.